Jul. 7 at 9:57 AM
$GILT $BCTX $OSPN $IP.MI — my "misread re-rating" watchlist, shared with honest pros & cons. I hold all four.
$GILT: Comtech deal builds a defense/aviation sat-comms story with a Re-Rating Case maybe , but 44% of revenue sits with 2 customers (With Comtech US Army License in House). My model recently downgraded it from Buy to REJECT — integration unproven. Still long
$OSPN: net cash, auth/cyber pivot. But market reads hardware, reality is SaaS. Model say "Watch" now.
$IP.MI: global leader in high-pressure pumps, ~22% margin of safety, but 2 years of flat/declining revenue — also REJECT in my model now.
$BCTX: Phase-3 oncology, positive DSMB, but a pure research position for me — no systematic buy signal, high dilution risk.
Not bullish calls — I hold these with full respect for the risks.
Not financial advice. No solicitation or offer. I am long the names above (conflict of interest). Do your own research; positions may change without notice. You bear all risk of loss.
